InflaRx N.V. Gains 50%
Wed, Apr 01, 2020 at 05:30 PM
InflaRx N.V. (IFRX:NASDAQ) rocketted at $5.73, representing a gain of 50%. On Tue 31 Mar 20, IFRX:NASDAQ touched a New 2-Week High of $3.82. The stock got featured on our News Catalysts scanner on Wed 01 Apr 20 at 01:51 PM in the 'BIOTECH' category. From Tue 17 Mar 20, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Mon 02 Mar 20 at $6.18 with a volume of 4M+.
About InflaRx N.V. (IFRX:NASDAQ)
InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.
Top 10 Gainers:
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 61.09%
- InflaRx N.V. (IFRX:NASDAQ), 50%
- Dynatronics Corporation (DYNT:NASDAQ), 48.2%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 43.41%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 42.38%
- Chembio Diagnostics, Inc. (CEMI:NASDAQ), 39.84%
- Citius Pharmaceuticals, Inc. (CTXR:NASDAQ), 36.64%
- Boxlight Corporation (BOXL:NASDAQ), 35.46%
- Safe-T Group Ltd (SFET:NASDAQ), 32.93%
- Athersys, Inc. (ATHX:NASDAQ), 32.67%